Evidence map›Paper›PMID 38561543›Full record

ArticleJournal of neurology2024

Big Multiple Sclerosis Data network: an international registry research network.

Anna Glaser, Helmut Butzkueven, Anneke van der Walt, Orla Gray, Tim Spelman, Chao Zhu, Maria Trojano, Pietro Iaffaldano, Mario A Battaglia, Giuseppe Lucisano and 13 more

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Big data in multiple sclerosis.Current opinion in neurology · 2026
    Review
  4. Detecting progressing events in multiple sclerosis clinics in real-time is possible: Yes.Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. The neurocognitive and neuropsychiatric manifestations of Susac syndrome: a brief review of the literature and future directions.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Anna GlaserDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Helmut ButzkuevenDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Anneke van der WaltDepartment of Neurology, The Alfred Hospital, Melbourne, VIC, Australia.
Orla GraySouth Eastern Health and Social Care Trust, Belfast, UK.
Tim SpelmanDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Chao ZhuDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Maria TrojanoSchool of Medicine, University "Aldo Moro", Bari, Italy.
Pietro IaffaldanoDepartment of Translational Biomedicine and Neurosciences, DiBraiN University of Bari Aldo Moro, Bari, Italy.
Mario A BattagliaResearch Department, Italian Multiple Sclerosis Foundation, Genoa, Italy.
Giuseppe LucisanoDepartment of Translational Biomedicine and Neurosciences, DiBraiN University of Bari Aldo Moro, Bari, Italy.
Sandra VukusicService de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France.
Irena VukusicService de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France.
Romain CaseyService de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, 69677, Bron, France.
Dana HorakovaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic.
Jiri DrahotaDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic.
Melinda MagyariDepartment of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, 2100, Copenhagen, Denmark.
Hanna JoensenThe Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Luigi PontieriThe Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Frederik ElberlingThe Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Pernilla KlyveDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Elena Flavia MouresanDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Lars ForsbergDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Jan HillertDepartment of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden. jan.hillert@ki.se.ORCID http://orcid.org/0000-0002-7386-6732

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Big Multiple Sclerosis Data (BMSD) network ( https://bigmsdata.org ) was initiated in 2014 and includes the national multiple sclerosis (MS) registries of the Czech Republic, Denmark, France, Italy, and Sweden as well as the international MSBase registry. BMSD has addressed the ethical, legal, technical, and governance-related challenges for data sharing and so far, published three scientific papers on pooled datasets as proof of concept for its collaborative design. DATA COLLECTION: Although BMSD registries operate independently on different platforms, similarities in variables, definitions and data structure allow joint analysis of data. Certain coordinated modifications in how the registries collect adverse event data have been implemented after BMSD consensus decisions, showing the ability to develop together. DATA MANAGEMENT: Scientific projects can be proposed by external sponsors via the coordinating centre and each registry decides independently on participation, respecting its governance structure. Research datasets are established in a project-to-project fashion and a project-specific data model is developed, based on a unifying core data model. To overcome challenges in data sharing, BMSD has developed procedures for federated data analysis. FUTURE PERSPECTIVES: Presently, BMSD is seeking a qualification opinion from the European Medicines Agency (EMA) to conduct post-authorization safety studies (PASS) and aims to pursue a qualification opinion also for post-authorization effectiveness studies (PAES). BMSD aspires to promote the advancement of real-world evidence research in the MS field.

Indexed as

Multiple SclerosisRegistriesBig DataHumansInformation DisseminationInternational CooperationMultiple sclerosisPatient data networkPatient registriesReal-world evidence

Identifiers

PMID38561543
PMCPMC11136763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.